Search research articles
Contact Us
Filters
Showing results (131-140 of 142) with videos related to
Page
of 15
Sort By:
Leukemia
|
September 10, 2010
Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)
M Q Lacy, S R Hayman, M A Gertz, et al.
British Journal of Haematology
|
January 16, 2007
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis
E M Ocio, R F J Schop, B Gonzalez, et al.
Leukemia
|
December 2, 2016
Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category
E Muchtar, A Dispenzieri, S K Kumar, et al.
Journal of Internal Medicine
|
April 26, 2017
Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis
E Muchtar, D S Dean, A Dispenzieri, et al.
Leukemia
|
July 27, 2016
Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
W I Gonsalves, S V Rajkumar, A Dispenzieri, et al.
Blood Cancer Journal
|
December 8, 2021
"Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma-the Mayo Clinic experience
I Vaxman, J Abeykoon, A Dispenzieri, et al.
Leukemia
|
November 5, 2004
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
A Dispenzieri, G A Wiseman, M Q Lacy, et al.
Blood Cancer Journal
|
February 18, 2017
Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma
N Tandon, S V Rajkumar, B LaPlant, et al.
Leukemia
|
September 19, 2017
Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains
S Sidana, N Tandon, A Dispenzieri, et al.
Leukemia
|
June 29, 2017
Natural history of t(11;14) multiple myeloma
A Lakshman, M Alhaj Moustafa, S V Rajkumar, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 142) with videos related to
Sort By:
Page
of 15
Leukemia
|
September 10, 2010
Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)
M Q Lacy, S R Hayman, M A Gertz, et al.
British Journal of Haematology
|
January 16, 2007
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis
E M Ocio, R F J Schop, B Gonzalez, et al.
Leukemia
|
December 2, 2016
Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category
E Muchtar, A Dispenzieri, S K Kumar, et al.
Journal of Internal Medicine
|
April 26, 2017
Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis
E Muchtar, D S Dean, A Dispenzieri, et al.
Leukemia
|
July 27, 2016
Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
W I Gonsalves, S V Rajkumar, A Dispenzieri, et al.
Blood Cancer Journal
|
December 8, 2021
"Real-life" data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma-the Mayo Clinic experience
I Vaxman, J Abeykoon, A Dispenzieri, et al.
Leukemia
|
November 5, 2004
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
A Dispenzieri, G A Wiseman, M Q Lacy, et al.
Blood Cancer Journal
|
February 18, 2017
Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma
N Tandon, S V Rajkumar, B LaPlant, et al.
Leukemia
|
September 19, 2017
Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains
S Sidana, N Tandon, A Dispenzieri, et al.
Leukemia
|
June 29, 2017
Natural history of t(11;14) multiple myeloma
A Lakshman, M Alhaj Moustafa, S V Rajkumar, et al.
Page
of 15